Autres langues Gufic Biosciences Limited NSE India S.E.

Actions

GUFICBIO

INE742B01025

Marché Fermé - NSE India S.E. Autres places de cotation 13:43:54 26/06/2024			Varia. 5j.	Varia. 1 janv.
355,9 ^INR	+0,86 %		+0,28 %	+12,47 %

31/05	Gufic Biosciences Limited annonce le départ à la retraite de Hemal M. Desai, responsable de la fiscalité et du personnel de direction	CI
30/05	Transcript : Gufic Biosciences Limited, Q4 2024 Earnings Call, May 30, 2024

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Gufic Biosciences Limited Announces Retirement of Hemal M. Desai, Head Taxation and Senior Management Personnel	31/05
Gufic Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024	29/05
Gufic Biosciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	29/05
Gufic Biosciences Limited Proposes Recommendation of Final Dividend for the Financial Year 2023-24	29/05
Gufic Biosciences Limited Approves Reconstitution of Various Committees	25/04
Gufic Biosciences Forms New Wholly-Owned Arm in Dubai	04/04
Gufic Biosciences Limited Incorporates Wholly Owned Subsidiary Company in Dubai	03/04
Gufic Biosciences Limited Announces Demise of Shrirang Vaidya, Independent Director, Chairman of Audit Committee and Nomination and Remuneration Committee and Member of Risk Management Committee	02/04
Gufic Biosciences Secures Patent in India	15/03
Gufic Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Gufic Biosciences Gets New Patent in India	31/01
Gufic Biosciences Forms New Pharmaceutical Subsidiary	20/11
Gufic Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Lumosa Therapeutics Co., Ltd. Approves the Exclusive Licensing Agreement with Gufic Biosciences for LT1001, A Long-Acting Analgesic Injection	09/11
Gufic Biosciences Limited announced that it has received INR 999.9 million in funding from Motilal Oswal Financial Services Limited	11/10/23
Gufic Biosciences Limited Approves Final Dividend for the Financial Year Ended March 31, 2023	30/09/23
Gufic Biosciences Limited Approves Incorporation of Wholly Owned Subsidiary in Dubai, UAE	27/09/23
Gufic Biosciences Granted Patent for its Invention	15/09/23
Gufic Biosciences Gets Nod from Australian, Brazilian Regulators for Parecoxib Sodium Lyophilized Powder	12/09/23
Gufic Biosciences Limited Receives Approval of TGA, Australia and the National Health Surveillance Agency, Brazil for Parecoxib 40Mg Injection	11/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Gufic Biosciences Limited NSE India S.E.

Actions

GUFICBIO

INE742B01025

Autres langues

Filtres